• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Medtronic (NY:MDT)

    81.06 +1.26 (+1.58%)
    Streaming Delayed Price Updated: 10:39 AM EDT, Jun 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Medtronic

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    18 19 Next >
    News headline image
    Former Medtronic CEO Bill Hawkins Joins Ketryx Board to Solve the AI Bottleneck in Life Sciences
    Cambridge, Massachusetts--(Newsfile Corp. - June 25, 2026) - Ketryx, the agentic continuous compliance platform... 
    Via Newsfile
    Topics Artificial Intelligence
    News headline image
    Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    N2Growth Named to Forbes' List of America's Best Executive Recruiting Firms for Tenth Consecutive Year
    Philadelphia, Pennsylvania--(Newsfile Corp. - May 5, 2026) - N2Growth, a global executive search and leadership advisory firm, has been... 
    Via Newsfile
    News headline image
    FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    The Infrastructure Play Hiding in Plain Sight Across Cardiac Care
    Issued on behalf of VentriPoint Diagnostics Ltd. 
    From Equity Insider
    Via GlobeNewswire
    News headline image
    Envoy Medical Appoints Chas McKhann to Board of Directors
    White Bear Lake, Minnesota--(Newsfile Corp. - April 16, 2026) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company... 
    Via Newsfile
    News headline image
    Telix Strengthens Board with Additional Director Appointments
    From Telix Pharmaceuticals Limited
    Via GlobeNewswire
    News headline image
    Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Universal adhesive patch for CGM and insulin pump, waterproof breathable transparent patch, pre-cut tape, CGM protection, skin-friendly patch for 10-14 days
    Via AB Newswire
    News headline image
    Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital Raises
    From Anteris Technologies Global Corp.
    Via GlobeNewswire
    News headline image
    Record-breaking CIIE 2025 Achievements Signal Global Momentum
    Via Press Release Distribution Service
    News headline image
    Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Orchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation Summit
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Pedro David Espinoza Releases Audiobook of “The Real ROI: Return on Inclusion”
    Via AB Newswire
    Topics Economy
    News headline image
    There’s a New Way to Treat AFib - Here’s What You Should Know
    Via NewsUSA
    News headline image
    2024 R&D Spending and Intensity Benchmarks
    Via PRLog
    Topics Supply Chain
    News headline image
    Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Orchestra BioMed Announces Publication of Clinical Data Demonstrating Favorable Blood Pressure and Hemodynamic Effects of AVIM Therapy in JACC: Clinical Electrophysiology
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    hyperCORE International Names New President
    July 29, 2025 -- Longtime Member and FOMAT CEO Nicholas Focil Appointed to Lead Global Research Site Network 
    Via 24-7 Press Release
    News headline image
    Not Just a Patch Earns FDA, EU Clearance for CGM Patches Line, Expanding Diabetes Support Offerings
    Via Press Release Distribution Service
    News headline image
    Bond Introduces World’s First Perpetual Smart Ring with Patent-Pending LifeDrive System
    Via Get News
    News headline image
    G3 Partners Opens Procomer Office in Silicon Valley to Accelerate U.S. Investment into Costa Rica
    Via Press Release Distribution Service
    News headline image
    Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities
    EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TNDM),(NYSE:NVO),(NASDAQ:PODD),(NYSE:MDT) EQNX::TICKER_END 
    Via FinancialNewsMedia
    News headline image
    Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities
    From FN Media Group LLC
    Via GlobeNewswire
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    18 19 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.